글로벌 모르셀레이터 시장 – 2031년까지의 산업 동향 및 예측

모르셀레이터 시장 분석 및 규모

자궁을 제거하는 최소 침습적 수술 절차인 복강경 자궁적출술은 모르셀레이터 시장의 주요 응용 분야입니다. 모르셀레이터는 자궁을 더 작은 조각으로 조각내어 큰 개방 절개보다는 작은 절개를 통해 추출할 수 있도록 하는 데 사용됩니다. 이 기술은 수술적 외상을 줄이고 흉터를 최소화하며 환자의 회복 시간을 단축합니다. 복강경 자궁적출술에서 모르셀레이터를 사용하는 것은 이러한 이점으로 인해 인기를 얻었으며 의료 기기 시장에서 수요를 주도하고 있습니다.

글로벌 모르셀레이터 시장 규모는 2023년에 1억 3,290만 달러로 평가되었으며, 2031년까지 2억 3,702만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 7.5%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

시장 정의

Morcellators are medical devices used during minimally invasive surgeries to cut larger tissues into smaller pieces, making them easier to remove from the body. They are commonly used in procedures such as laparoscopic hysterectomies and myomectomies to extract uterine fibroids or other growths through small incisions.

Morcellators Market Dynamics

Drivers                                                                                          

• Growing Preference for Minimally Invasive Surgeries

Patients and healthcare providers favor these procedures due to their numerous benefits, including reduced postoperative pain, shorter hospital stays, quicker recovery times, and minimal scarring. These advantages lead to increased patient satisfaction and improved surgical outcomes. As a result, there is a higher demand for advanced surgical tools such as morcellators, which facilitate these less invasive techniques, thereby propelling market growth. This trend is particularly prominent in gynecological surgeries, such as laparoscopic hysterectomy and myomectomy.

• Increasing Prevalence of Gynecological Disorders

The increasing prevalence of gynecological disorders, such as uterine fibroids and endometriosis often require surgical intervention, and the growing number of cases heightens the demand for effective treatment options. Morcellators, which facilitate minimally invasive procedures such as laparoscopic hysterectomy and myomectomy, offer a less invasive alternative to traditional open surgeries. As more women seek treatment for these disorders, the adoption of morcellators in surgical practices is expected to rise, driving market growth.

Opportunities

• Expanding Healthcare Infrastructure

As healthcare facilities improve and expand, particularly in emerging economies, there is greater access to advanced surgical procedures and technologies such as minimally invasive surgeries using morcellators. These developments enable healthcare providers to offer more sophisticated treatment options to patients suffering from conditions such as uterine fibroids and other gynecological disorders. Additionally, enhanced infrastructure supports the training of healthcare professionals in the use of morcellators, increasing their adoption and utilization in various surgical settings.

• Rising Advancements in Medical Technology

Advancements in medical technology have led to the development of safer, more precise, and efficient morcellator devices. The improvements in blade design and tissue containment systems reduce the risk of complications such as tissue dissemination and infection. Furthermore, technological advancements have enabled the integration of advanced imaging technologies, such as ultrasound and MRI, which assist surgeons in better targeting tissues for morcellation. Enhanced materials and ergonomic designs also contribute to easier handling and improved patient outcomes, encouraging healthcare providers to adopt morcellators for minimally invasive surgeries such as laparoscopic hysterectomy and myomectomy.

Restraints/Challenges

• Growing Safety Concerns

Growing safety concerns is the potential for morcellation to spread undiagnosed malignant tissue, such as uterine sarcomas, which can significantly worsen patient outcomes. This has prompted regulatory agencies to issue warnings and guidelines regarding the use of morcellators, impacting their adoption in clinical practice. Healthcare providers and patients alike are increasingly cautious due to these safety risks, leading to decreased confidence and utilization of morcellation techniques, especially in cases where malignancy cannot be definitively ruled out preoperatively.

• Stringent Regulatory Requirements

Regulatory bodies, concerned about the potential risks associated with morcellation, have implemented stringent guidelines and safety standards. These requirements often mandate thorough clinical evaluations, rigorous testing of device efficacy and safety, and strict reporting of adverse events. Compliance with these regulations can be time-consuming and costly for manufacturers, leading to delays in product approvals or market entry. Moreover, regulatory scrutiny can deter healthcare providers from adopting morcellators, particularly in regions where concerns over safety and efficacy are heightened.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In September 2019, Medtronic launched the Evolut PRO+ transcatheter aortic valve replacement (TAVR) system in the U.S. TAVR is a minimally invasive procedure used to treat severe aortic stenosis in patients who are at high risk for traditional open-heart surgery. The Evolut PRO+ system builds upon previous generations with enhanced features aimed at improving valve performance and patient outcomes, expanding treatment options for individuals with severe aortic valve disease
• In September 2019, Abbott initiated the TRILUMINATE pivotal trial for its TriClip transcatheter tricuspid valve repair system. This system is designed to address tricuspid regurgitation, a condition where blood flows backwards into the right atrium due to improper closure of the tricuspid valve. The TriClip procedure aims to reduce regurgitation and improve heart function without the need for open-heart surgery, offering a less invasive treatment option for patients suffering from this challenging valve disorder

Morcellators Market Scope

The market is segmented on the basis of type, application, usage type and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Electric Morcellator
  • Hysteroscopic Morcellator
  • Laparoscopic Morcellator
• Manual Morcellator
• Others

 Usage Type

• Reusable
• Reposable
• Disposable

Application

• Uterine Fibroids
• Hysteroscopy
• Laparoscopy
• Others

 End Use

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Morcellators Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, type, application, usage type and end use as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.

North America dominates the market is attributed to its robust healthcare infrastructure and significant advancements in laparoscopic technology. These factors ensure high-quality medical care and widespread adoption of innovative surgical tools. Additionally, strong investments in healthcare and a focus on minimally invasive procedures further bolster the region's leading position in this market.

Asia-Pacific is expected to experience the highest growth rate in the market due to increasing health awareness among the population and a growing demand for advanced medical technologies. As people become more conscious of their health, there is a greater emphasis on adopting innovative medical solutions, propelling market growth in this region.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

의료 인프라 성장 설치 기반 및 신기술 침투

이 시장은 또한 자본 장비에 대한 의료 지출의 모든 국가별 성장, 시장에 대한 다양한 종류의 제품의 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 시장에 미치는 영향에 대한 자세한 시장 분석을 제공합니다. 이 데이터는 2016-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 모르셀레이터 시장 분석

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• 블루엔도(미국)
• 칼 스토르츠(독일)
• Richard Wolf GmbH(독일)
• 프랭클린 템플턴. (미국)
• 루메니스 비 리미티드(이스라엘)
• 홀로직 주식회사(미국)
• 스미스+네퓨(미국)
• 올림푸스 주식회사(일본)
• 누바그(독일)
• LiNA Medical ApS(덴마크)
• 메드트로닉(아일랜드)
• 스트라이커(미국)
• 쿡(미국)
• BD(미국)

SKU-53282